Oramed Pharmaceuticals, Inc.

( )
ORMP After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
SAVACassava Sciences, Inc. -4.52%48.580.0%$723.51m
GWPHGW Pharmaceuticals Plc -0.28%214.256.1%$392.53m
HZNPHorizon Therapeutics Plc 0.38%90.915.6%$195.15m
JAZZJazz Pharmaceuticals Plc -1.58%168.042.3%$188.22m
VRXValeant Pharmaceuticals International, Inc. 0.58%31.4614.1%$185.11m
BHCBausch Health Cos., Inc. 0.58%31.460.0%$142.45m
CTLTCatalent, Inc. 1.07%113.452.1%$115.04m
ICLRICON plc -2.04%180.684.2%$85.81m
ARGXargenx SE -2.59%330.680.0%$81.68m
TNXPTonix Pharmaceuticals Holding Corp. -2.46%1.190.2%$68.33m
ZYNEZynerba Pharmaceuticals, Inc. 0.79%4.506.0%$58.97m
PRGOPerrigo Co. Plc -1.64%40.116.8%$52.68m
AMRNAmarin Corp. Plc -3.02%6.741.5%$51.52m
UTHRUnited Therapeutics Corp. -0.96%167.1814.1%$45.85m
PBHPrestige Consumer Healthcare, Inc. 0.12%41.824.0%$43.23m

Company Profile

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.